Reaction
Sinus Polyp reporting signals
As of the last recalculation, Sinus Polyp appears in 569 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is MICAFUNGIN SODIUM (PRR 66.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Micafungin Sodium | 15 | 66.4 | 66.6 |
| Ciclesonide | 22 | 61.4 | 61.5 |
| Lumacaftor And Ivacaftor | 9 | 39.0 | 39.1 |
| Mometasone Furoate | 40 | 37.7 | 37.7 |
| Melphalan | 19 | 31.6 | 31.6 |
| Melphalan Hydrochloride | 19 | 28.6 | 28.7 |
| Budesonide And Formoterol Fumarate Dihydrate | 56 | 23.3 | 23.3 |
| Mepolizumab | 30 | 23.3 | 23.3 |
| Loratadine And Pseudoephedrine Sulfate | 5 | 23.2 | 23.2 |
| Bendamustine Hydrochloride | 7 | 21.6 | 21.6 |
| Thalidomide | 20 | 20.6 | 20.6 |
| Omalizumab | 43 | 19.9 | 19.9 |
| Bendamustine Hcl | 8 | 19.1 | 19.1 |
| Benralizumab | 9 | 16.7 | 16.7 |
| Dornase Alfa | 7 | 13.2 | 13.2 |